Sunil Iyengar

2.8k total citations · 1 hit paper
54 papers, 1.0k citations indexed

About

Sunil Iyengar is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Sunil Iyengar has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 22 papers in Genetics and 11 papers in Oncology. Recurrent topics in Sunil Iyengar's work include Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (19 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Sunil Iyengar is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (19 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Sunil Iyengar collaborates with scholars based in United Kingdom, United States and Canada. Sunil Iyengar's co-authors include David Cunningham, Dima El‐Sharkawi, Franck Morschhauser, Carmen Kahatt, Emanuele Zucca, Sandy Amorim, R. B. Lynn, Lionel Karlin, Mary Gleeson and Edward J.P. Charrette and has published in prestigious journals such as The Lancet, Neuron and Journal of Clinical Oncology.

In The Last Decade

Sunil Iyengar

47 papers receiving 937 citations

Hit Papers

Bromodomain inhibitor OTX015 in patients with lymphoma or... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
    2016 328 citations Sandy Amorim, Anastasios Stathis et al. The Lancet Haematology profile →

Peers

Sunil Iyengar
Linda D. Cooley United States
Joost M. Meijer Netherlands
Catharina M.P. Vos Netherlands
Carol S. Bruggers United States
Laurie Ford United States
Julie Morris United Kingdom
Robert E. Pyatt United States
Deniz Peker United States
Lisa Murray Australia
Amelia K. Scaffidi Australia
Linda D. Cooley United States
Sunil Iyengar
Citations per year, relative to Sunil Iyengar Sunil Iyengar (= 1×) peers Linda D. Cooley

Countries citing papers authored by Sunil Iyengar

Since Specialization
Citations

This map shows the geographic impact of Sunil Iyengar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Iyengar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Iyengar more than expected).

Fields of papers citing papers by Sunil Iyengar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunil Iyengar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Iyengar. The network helps show where Sunil Iyengar may publish in the future.

Co-authorship network of co-authors of Sunil Iyengar

This figure shows the co-authorship network connecting the top 25 collaborators of Sunil Iyengar. A scholar is included among the top collaborators of Sunil Iyengar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunil Iyengar. Sunil Iyengar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicol, Jennifer, Andrew T. Hulton, Renata Walewska, et al.. (2025). Physical Activity, Symptoms, Quality of Life and Exercise Program Preferences in People With Chronic Lymphocytic Leukaemia. eJHaem. 6(4). e70100–e70100. 1 indexed citations
2.
Walewska, Renata, Toby A. Eyre, Adrian Bloor, et al.. (2025). 2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology. 207(6). 2296–2313.
3.
Potter, Michael, Emma Nicholson, Ian Chau, et al.. (2024). Excellent Outcomes with Brentuximab-Nivolumab for Relapsed/ Refractory Primary Mediastinal B-Cell Lymphoma in the Real-World Setting. Blood. 144(Supplement 1). 3085–3085.
4.
Proszek, Paula, Paul Carter, Andrew Feber, et al.. (2024). Incidental finding of leukaemia in circulating tumour DNA— the importance of a molecular tumour board. PubMed. 2(1). 12–12. 1 indexed citations
5.
Chen, Wen, et al.. (2024). Music and medicine: quickening the tempo of progress. The Lancet. 403(10433). 1213–1215. 2 indexed citations
6.
Roddie, Claire, Lorna Neill, Wendy Osborne, et al.. (2023). Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma. Blood Advances. 7(12). 2872–2883. 64 indexed citations
7.
Walewska, Renata, Toby A. Eyre, Sally F. Barrington, et al.. (2023). Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline. British Journal of Haematology. 204(1). 86–107. 8 indexed citations
8.
Sharma, Bhupinder, Vasiliki Michalarea, Mary Gleeson, et al.. (2023). Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital. Clinical Lymphoma Myeloma & Leukemia. 24(1). 48–54.
9.
Eyre, Toby A., Mark Bishton, Rory McCulloch, et al.. (2023). Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology. 204(1). 108–126. 10 indexed citations
10.
11.
Casulo, Carla, Michael Herold, Wolfgang Hiddemann, et al.. (2022). Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study. Clinical Lymphoma Myeloma & Leukemia. 23(1). 40–48. 14 indexed citations
12.
O’Connell, Rachel, Bhupinder Sharma, Aia Mehdi, et al.. (2021). Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). European Journal of Surgical Oncology. 48(4). 748–751.
13.
Sharma, Bhupinder, Erika Pace, Ayoma D. Attygalle, et al.. (2020). Breast Implant–associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms. Radiographics. 40(3). 609–628. 32 indexed citations
14.
15.
Patel, Kalpesh, et al.. (2019). A comparative quantitative - qualitative assessment in orthodontic treatment of white spot lesion treated with 3 different commercially available materials - In vitro study. Journal of Clinical and Experimental Dentistry. 11(9). 0–0. 14 indexed citations
16.
17.
Cunningham, Joel, Sunil Iyengar, & Bhupinder Sharma. (2017). Evolution of lymphoma staging and response evaluation: current limitations and future directions. Nature Reviews Clinical Oncology. 14(10). 631–645. 22 indexed citations
18.
Amorim, Sandy, Anastasios Stathis, Mary Gleeson, et al.. (2016). Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. The Lancet Haematology. 3(4). e196–e204. 328 indexed citations breakdown →
19.
Iyengar, Sunil, et al.. (2007). Relapsed B‐CLL/small B‐lymphocytic lymphoma presenting as bronchiectasis. European Journal Of Haematology. 79(3). 274–275. 1 indexed citations
20.
Iyengar, Sunil, et al.. (1973). Anoxic cardiac arrest: An experimental and clinical study of its effects. Journal of Thoracic and Cardiovascular Surgery. 66(5). 722–730. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda D. Cooley Breakdown of academic impact, for papers by Joost M. Meijer Breakdown of academic impact, for papers by Catharina M.P. Vos Breakdown of academic impact, for papers by Carol S. Bruggers Breakdown of academic impact, for papers by Laurie Ford Breakdown of academic impact, for papers by Julie Morris Breakdown of academic impact, for papers by Robert E. Pyatt Breakdown of academic impact, for papers by Deniz Peker Breakdown of academic impact, for papers by Lisa Murray Breakdown of academic impact, for papers by Amelia K. Scaffidi
Rankless by CCL
2026